BIOCRYST PHARMACEUTICALS INC 10-Q filing
Filed 2025-08-05 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001628280-25-037795
- Form type
- 10-Q
- CIK
- 0000882796
- Primary document
- https://www.sec.gov/Archives/edgar/data/882796/000162828025037795/bcrx-20250630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BIOCRYST PHARMACEUTICALS INC.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Cost Of Revenue | $7.4M | - | - |
| Operating Income | $51.0M | - | - |
| Net Income | $5.1M | - | - |
| Eps Basic | 0.02 | - | - |
| Eps Diluted | 0.02 | - | - |
| Cash And Equivalents | $88.0M | - | - |
| Total Assets | $457.2M | - | - |
| Total Liabilities | $878.8M | - | - |
| Shareholders Equity | $-421.6M | - | - |
| Operating Cash Flow | $13.8M | - | - |